How Sensex, Nifty rallied 200% under PM Modi’s record-breaking tenure

Indian equity markets delivered strong long-term returns during Prime Minister Narendra Modi’s tenure, with the Sensex and Nifty gaining around 200% since 2014. Metals emerged as the top-performing sector, while midcaps significantly outperformed broader indices, highlighting sustained wealth creation despite market cycles and evolving economic conditions.

Sebi proposes consolidated disclosure of executive pay at asset managers

India’s markets regulator, SEBI, has proposed a change for asset management companies. Executives and high earners in these firms may soon have their pay disclosed together, not individually. This aims to give investors a clearer picture of senior management compensation. SEBI is seeking public feedback on this proposal until June 30.

Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tablets

Concord Biotech’s shares surged over 6% after receiving USFDA approval for its Tofacitinib Tablets in 5 mg and 10 mg strengths. This approval for rheumatoid arthritis and other conditions is expected to bolster its U.S. market presence and product portfolio, targeting a $500 million market opportunity.

Utkal Speciality Industries IPO: Check GMP, price band, subscription and other details

Utkal Speciality Industries India’s IPO opens Wednesday, aiming to raise Rs 34.5 crore with shares priced between Rs 62-66. The SME issue, closing June 12, targets expansion and debt reduction. Despite zero grey market premium, indicating cautious listing expectations, the company shows steady financial growth. Retail investors receive a significant allocation.